Serine/threonine-protein kinase DCLK3

BE0009431ProteinHumansDCLK3

Serine/threonine-protein kinase DCLK3 (Humans) is a protein target in DrugBank. It is acted on by 1 drug in DrugBank.

Gene name
DCLK3
UniProtKB entry
Q9C098Swiss-Prot
Cellular location
Cytoplasm
Residues / weight
648 residues · 73,814 Da
Also known as
2.7.11.1 · DCAMKL3 · DCDC3C · Doublecortin domain-containing protein 3C · Doublecortin-like and CAM kinase-like 3

Resolves to

Protein
UniProtQ9C098UniProt nameDCLK3_HUMAN
Gene
HGNCHGNC:19005NCBI Gene85443GeneCardsDCLK3
Pharmacology
KEGGhsa:85443
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
3GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Serine/threonine-protein kinase DCLK3, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In